Vasgene Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Vasgene Therapeutics

Access the complete profile.

Vasgene Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	5241 Insurance Carriers
Additional NAICS Codes	5417 Scientific Research & Development Services 541711 Research & Development in Biotechnology
Address	1929 Zonal Ave Los Angeles, CA 90033

Note: Revenues for privately held companies are statistical evaluations.


Vasgene Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Vasgene Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Vasgene Therapeutics is classified as operating in the Insurance Carriers industry, NAICS Code 5241.

Vasgene Therapeutics Annual Revenue and Growth Rate

Vasgene Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Vasgene Therapeutics's revenues are gauged from an analysis of company filings.

Vasgene Therapeutics's Income Statement (based on Industry Averages)

Vasgene Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Vasgene Therapeutics is developing and marketing. Vasgene Therapeutics doesn't have any recent trademark applications, indicating Vasgene Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
VASGENE DIAGNOSTIC RECOMBINANT VECTORS FOR CLONING, MANIPULATING AND EXPRESSING RECOMBINANT DNA FOR SCIENTIFIC AND MEDICAL RESEARCH USE; DIAGNOSTIC CHEMICAL, BIOCHEMICAL, BIOLOGICAL AND BIOTECHNOLOGICAL PREPARATIONS AND SUBSTANCES, NAMELY, RECOMBINANT VECTORS FOR SCIENTIFIC AND MEDICAL RESEARCH USE; CHEMICAL, BIOCHEMICAL, BIOLOGICAL AND BIOTECHNOLOGICAL PREPARATIONS AND SUBSTANCES, NAMELY, CELL GROWTH SUPPORT STRUCTURES AND SUBSTRATES FOR USE IN CELL CULTURES AND INDUSTRIAL, SCIENTIFIC AND MEDICAL RESEARCH; CHEMICAL, BIOCHEMICAL, BIOLOGICAL AND BIOTECHNOLOGICAL PREPARATIONS AND SUBSTANCES FOR USE IN THE MANUFACTURE OF MEDICINES, PHARMACEUTICALS, DIAGNOSTICS, VACCINES, ANTIBODIES AND BIOLOGICAL MOLECULES; SYNTHETIC RESINS, PREPARATIONS AND SUBSTANCES FOR USE IN THE MANUFACTURE OF MEDICINES, PHARMACEUTICALS, DIAGNOSTICS, VACCINES, ANTIBODIES AND BIOLOGICAL MOLECULES; AND AUXILIARY PREPARATIONS, CARRIERS AND SUBSTANCES FOR USE IN THE MANUFACTURE OF MEDICINES, PHARMACEUTICALS, DIAGNOSTICS, VACCINES, ANTIBODIES AND BIOLOGICAL MOLECULES	05/20/2002
VEGLIN [ PHARMACEUTICAL PREPARATIONS AND SUBSTANCES, NAMELY, THERAPEUTIC COMPOUNDS FOR THE TREATMENT OF ANGIOGENESIS-RELATED DISEASES AND DISORDERS, CHRONIC INFLAMMATORY DISEASES AND DISORDERS, MULTIPLE SCLEROSIS, PSORIASIS, ARTHRITIS, SURGICAL ADHESIONS AND CARDIOVASCULAR GRAFTS; ] PHARMACEUTICAL PREPARATIONS AND SUBSTANCES, NAMELY, ANGIOGENESIS INHIBITOR PROTEIN COMPOSITIONS FOR THE TREATMENT OF DISEASES, DISORDERS AND BIOLOGICAL PROCESSES THAT ARE MEDIATED BY ANGIOGENESIS, NAMELY, CANCER, [ MACULAR DEGENERATION, DIABETIC RETINOPATHY, CROHN'S DISEASE, PSORIASIS AND ARTHRITIS; ] PHARMACEUTICAL PREPARATIONS AND SUBSTANCES, NAMELY, RECOMBINANT VECTORS FOR CLONING, MANIPULATING OR EXPRESSING RECOMBINANT DNA FOR MEDICAL USE; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES, NAMELY, RECOMBINANT VECTORS FOR LABORATORIES, DIAGNOSTICS AND ANALYTICS FOR MEDICAL USE	02/19/2002

See all trademarks and details in the Full Report.

Market Share of Vasgene Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Vasgene Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
CENTRUM VALLEY HOLDINGS	Clarion, IA	100
ELEVANCE HEALTH	Indianapolis, IN	44
SECURIAN LIFE INSURANCE	Saint Paul, MN	33
ATH HOLDING	Indianapolis, IN	31
HUMANA	Louisville, KY	30
STATE FARM MUTUAL AUTOMOBILE INSURANCE	Bloomington, IL	26
AMALGAMATED LIFE INSURANCE COMPANY EMPLOYEE BENEFIT FUND	White Plains, NY	25
PRUDENTIAL INSURANCE	Newark, NJ	24
AMERICAN INTERNATIONAL GROUP	New York, NY	13

Nearby Competitors

These companies are similar in business line and location to Vasgene Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
MERCURY INSURANCE SERVICES	Los Angeles, CA	100
COOPERATIVE OF AMERICAN PHYSICIANS	Los Angeles, CA	4
UNISOURCE NATIONAL LENDER SERVICES	Los Angeles, CA	2
GREG FACKTOR & ACCOCIATES	Los Angeles, CA	0
3INSYS LIMITED LIABILITY	Los Angeles, CA	0
VASGENE THERAPEUTICS	Los Angeles, CA	0

Future Competition: Vasgene Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Vasgene Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)